DR. MICHAEL M. ITTMANN, MD
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas K6016
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
2002 Holcombe Blvd, Houston, TX 77030
Phone
(713) 794-7874
Personal information
See more information about MICHAEL M. ITTMANN at radaris.comName
Address
Phone
2422 Goldsmith St, Houston, TX 77030
Houston, TX
2437 Goldsmith St, Houston, TX 77030
2422 Goldsmith St, Houston, TX 77030
Organization information
See more information about MICHAEL M. ITTMANN at bizstanding.comMichael M Ittmann
1 Baylor Plz, Houston, TX 77030
Industry:
Grant Reviewer
Owner:
Michael Ittmann Owner, inactive
Professional information
Michael Murrey Ittmann, Houston TX
Specialties:
Pathology, Anatomic Pathology
Work:
Houston Veterans Affairs Medical Center
2002 Holcombe Blvd, Houston, TX 77030
2002 Holcombe Blvd, Houston, TX 77030
Education:
Case Western Reserve University(1983)
Dr. Michael M Ittmann, Houston TX - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
2002 Holcombe Blvd, Houston 77030
(713) 794-7874 (Phone)
HOUSTON VETERANS AFFRS MED CTR
2002 Holcombe Blvd SUITE 111H, Houston 77030
(713) 794-7111 (Phone), (713) 794-7733 (Fax)
(713) 794-7874 (Phone)
HOUSTON VETERANS AFFRS MED CTR
2002 Holcombe Blvd SUITE 111H, Houston 77030
(713) 794-7111 (Phone), (713) 794-7733 (Fax)
Certifications:
Anatomic Pathology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Case Western Reserve University
Nyu Langone Medical Center
Case Western Reserve University
Nyu Langone Medical Center
Genetic Markers Associated With Benign Prostatic Hyperplasia
US Patent:
2006019, Aug 31, 2006
Filed:
Jan 25, 2006
Appl. No.:
11/339733
Inventors:
Jonathan Levitt - Houston TX, US
Kevin Slawin - Houston TX, US
Eduardo Canto - Houston TX, US
David Spencer - Houston TX, US
Michael Ittmann - Houston TX, US
Kevin Slawin - Houston TX, US
Eduardo Canto - Houston TX, US
David Spencer - Houston TX, US
Michael Ittmann - Houston TX, US
Assignee:
BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:
C12Q 1/68, G01N 33/574
US Classification:
435006000, 435007230
Abstract:
The present invention regards expression profiles of one or more nucleic acids indicative of the presence of, susceptibility to, and/or predicting response to therapy of benign prostatic hyperplasia (BPH) in an individual. The present invention identifies pathways not previously associated with BPH, therefore presenting novel diagnostic and therapeutic targets for the condition.